Preoperative fibrin monomer measurement allows risk stratification for high intraoperative blood loss in elective surgery

We recently demonstrated that patients with increased blood loss due to intraoperative coagulopathy show a persistent pre-, intra- and postoperative increase in fibrin monomer concentration. We thus tested the hypothesis that preoperative fibrin monomer concentrations can be used as a risk indicator for intraoperative blood loss in a study designed for diagnostic test evaluation in 168 patients admitted to the surgical service of our hospital. Intraoperative blood loss increased with preoperative fibrin monomer concentration (median blood loss of 50, 100, 200 and 400 ml in preoperative fibrin monomer quartile groups 1 to 4, p<0.001, ANOVA on ranks; interquartile comparisons p < 0.05 (4/6), Mann Whitney Rank Sum test). In contrast, intraoperative blood loss was unrelated to preoperative values of prothrombin time, activated partial thromboplastin time and platelet count. By multivariate (logistic regression) analysis, only fibrin monomer remained a significant predictor of intraoperative blood loss > 500 ml when age, gender, BMI, fibrin monomer and the different types of surgical procedures (tumor surgery, vascular surgery, cholecystectomy, gastric banding, varicous vein surgery and hernia repair) were included as independent variables. Most importantly, accuracy evaluation showed that preoperative fibrin monomer concentration < 3 microg/l excluded intraoperative blood loss > 500 ml with 92% sensitivity and 95% negative predictive value. These results support our hypothesis that preoperative fibrin monomer concentrations are related to intraoperative blood loss in elective surgery. Fibrin monomer should be further investigated for it's potential to serve as a routine tool for preoperative risk stratification of intraoperative bleeding.

[1]  A. Chao,et al.  Prediction of bleeding diathesis in patients undergoing cardiopulmonary bypass during cardiac surgery: viscoelastic measures versus routine coagulation test. , 1997, Acta anaesthesiologica Sinica.

[2]  W. Geerts,et al.  Prevention of Deep Vein Thrombosis after Major Knee Surgery - A Randomized, Double-Blind Trial Comparing a Low Molecular Weight Heparin Fragment (Enoxaparin) to Placebo , 1992, Thrombosis and Haemostasis.

[3]  S. Dubos,et al.  Safety of preoperative enoxaparin in head and neck cancer surgery , 1995, Head & neck.

[4]  P. J. Mayer,et al.  Coagulopathies associated with major spinal surgery. , 1989, Clinical orthopaedics and related research.

[5]  F. Mcginn.  Effects of haemorrhage upon surgical operations , 1976, The British journal of surgery.

[6]  M. Schäfer,et al.  Predictive factors for the type of surgery in acute cholecystitis. , 2001, American journal of surgery.

[7]  C. Loinaz,et al.  Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. , 1998, Hepato-gastroenterology.

[8]  K. Mattox,et al.  Intraoperative Detection of Traumatic Coagulopathy Using the Activated Coagulation Time , 2003, Shock.

[9]  G. Klintmalm,et al.  The impact of operative bleeding on outcome in transplantation of the liver. , 1993, Surgery, gynecology & obstetrics.

[10]  L. Brath,et al.  Do "screening" coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy? , 1994, Chest.

[11]  A. Feinstein,et al.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.

[12]  B. Karlan,et al.  Perioperative coagulopathy in patients undergoing primary cytoreduction , 1993, Cancer.

[13]  A. Berchuck,et al.  Preoperative Coagulation Testing on a Gynecologic Oncology Service , 1994, Obstetrics and gynecology.

[14]  V. Jeevanandam,et al.  Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. , 1996, Circulation.

[15]  D. Royston,et al.  Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. , 2001, British journal of anaesthesia.

[16]  T. Schnider,et al.  Decreased Factor XIII Availability for Thrombin and Early Loss of Clot Firmness in Patients with Unexplained Intraoperative Bleeding , 2004, Anesthesia and analgesia.

[17]  B. Lämmle,et al.  Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[18]  K. Leslie,et al.  Coagulation Studies in Preoperative Neurosurgical Patients , 2001, Anaesthesia and intensive care.

[19]  G. Nuttall,et al.  Coagulation tests predict bleeding after cardiopulmonary bypass. , 1997, Journal of cardiothoracic and vascular anesthesia.

[20]  S. Handler,et al.  Preoperative history and coagulation screening in children undergoing tonsillectomy. , 1992, Pediatrics.

[21]  G. Lowe,et al.  Fibrinogen, fibrin turnover, endothelial products and vascular surgery , 1997, The British journal of surgery.

[22]  N. Grenier,et al.  D-dimer Strategy in Thrombosis Exclusion , 1998, Thrombosis and Haemostasis.

[23]  A. Origone,et al.  Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent post-operative deep venous thrombosis. , 1988, Current medical research and opinion.

[24]  B. Spiess,et al.  Endothelial cell injury in cardiovascular surgery: the procoagulant response. , 1996, The Annals of thoracic surgery.

[25]  Stephanie A. Mulherin,et al.  Spectrum Bias or Spectrum Effect? Subgroup Variation in Diagnostic Test Evaluation , 2002, Annals of Internal Medicine.

[26]  T. Aikou,et al.  Intraoperative risk factors associated with hepatic resection , 1995, The British journal of surgery.

[27]  W. Korte,et al.  Preoperative Values of Molecular Coagulation Markers Identify Patients at Low Risk for Intraoperative Haemostatic Disorders and Excessive Blood Loss , 1998, Clinical chemistry and laboratory medicine.